Addressing the Measles-Mumps-Rubella Revaccination Guidelines for Allogenic Bone Marrow Transplant Patients: A Response to the American Society for Transplantation and Cellular Therapy 2019 Position Statement

Affiliations

¹ Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
² Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California. Electronic address: GSchiller@mednet.ucla.edu.

Free article

Comment

Kevin Perez et al. Biol Blood Marrow Transplant. 2020 Jul.

Free article

. 2020 Jul;26(7):e171-e172.

doi: 10.1016/j.bbmt.2020.03.017. Epub 2020 Mar 21.

¹ Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
² Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California. Electronic address: GSchiller@mednet.ucla.edu.

No abstract available

Comment on

Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy.
Pergam SA, Englund JA, Kamboj M, Gans HA, Young JH, Hill JA, Savani B, Chemaly RF, Dadwal SS, Storek J, Duchin J, Carpenter PA. Pergam SA, et al. Biol Blood Marrow Transplant. 2019 Nov;25(11):e321-e330. doi: 10.1016/j.bbmt.2019.07.034. Epub 2019 Aug 5. Biol Blood Marrow Transplant. 2019. PMID: 31394271 Review.